PRESENTATION

Q3 2025 — Presentation

Q3 2025PDF · 43 pages6.3 MB


-- 1 of 43 --



-- 2 of 43 --



-- 3 of 43 --



-- 4 of 43 --

Americas 50% Europe/Mid-East/Africa 45% Asia-Pacific 5%

-- 5 of 43 --



-- 6 of 43 --



-- 7 of 43 --

Tools
• • •
•
•
•
• •
•
•
•
•
•
•

-- 8 of 43 --



-- 9 of 43 --

✓
✓
✓
✓ ✓
✓

-- 10 of 43 --

18% Average

-- 11 of 43 --

$51 $60
106 110

-- 12 of 43 --



-- 13 of 43 --



-- 14 of 43 --



-- 15 of 43 --



-- 16 of 43 --



-- 17 of 43 --



-- 18 of 43 --

•
•
•
•
•
•
•
•
•

-- 19 of 43 --

Link with solid fill
Link with solid fill
Link with solid fill
Link with solid fill
Link with solid fill
Link with solid fill

-- 20 of 43 --

•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•

-- 21 of 43 --

•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•

-- 22 of 43 --

$1,403
$1,778
$1,652
$1,357
$1,731
$427 $594 $529 $149 $397
2020 2021 2022 2023 2024
Net Revenue Operating Income
2023 2025E 2030E
($M)
$6.7 billion
Combination
creates a global
scaled, diversified
pharmaceuticals
leader €24.9 billion
Altice France’s
landmark
agreement with
creditors €16.0 billion
CD&R acquired a
controlling 50%
stake in Sanofi’s
consumer health
unit, Opella $26.6 billion
Proposed
acquisition to
create America’s
largest clean
power generation
provider $23.0 billion
Proposed
acquisition and
separation to
create a leading
beverage player
and a global
coffee champion

-- 23 of 43 --

• • •
• • •
• • •
• • •
• • •
• • •

-- 24 of 43 --

•
•
•
•

-- 25 of 43 --



-- 26 of 43 --

•
•
•
•
•
•
•
•
•

-- 27 of 43 --



-- 28 of 43 --



-- 29 of 43 --

23% 26% 21% 7% 14%
$-
$200
$400
$600
2020 2021 2022 2023 2024
Asset Management Financial Advisory Firm-wide Operating Margin
37% 38%
31% 28% 24%
2020 2021 2022 2023 2024
30% 33% 32%
11%
23%
2020 2021 2022 2023 2024
($M)

-- 30 of 43 --

$M
3,106 3,179
3,402 3,291 3,263
2020 2021 2022 2023 2024
Professionals Managing Directors
$2,524
$3,139
$2,769
$2,440
$2,890
59.5% 58.5% 59.8% 69.8% 65.9%
17.1% 15.0% 18.7% 23.4% 19.9%
2020 2021 2022 2023 2024
Net Revenue Compensation Ratio Non-Compensation Ratio

-- 31 of 43 --

$500 $500 $400 $300
$1,172
$200
2025 2028 2029 2031 2035
Senior notes Cash & cash equivalents Undrawn revolver
•
•
•
•
•

-- 32 of 43 --

113.9 114.2
103.2 97.5 104.4 110.4
2.9 9.1 19.7 2.8 1.4
2020 2021 2022 2023 2024 3Q25
Diluted Weighted Avg Shares Shares Repurchased
$1.88 $1.88 $1.97 $2.00 $2.00
$1.50
2020 2021 2022 2023 2024 9M'25
(Shares in millions)

-- 33 of 43 --



-- 34 of 43 --



-- 35 of 43 --



-- 36 of 43 --



-- 37 of 43 --



-- 38 of 43 --



-- 39 of 43 --



-- 40 of 43 --

2020 	2021 	2022 	2023 	2024 	2020 	2021 	2022 	2023 	2024 	2020 	2021 	2022 	2023 	2024
Adjusted Net Revenue 	$1,403 $1,778 $1,652 $1,357 $1,731 $1,111 $1,329 $1,099 $1,068 $1,100 $2,524 $3,139 $2,769 $2,440 $2,890
% Growth 	3% 	27% 	(7%) (18%) 	28% 	(4%) 	20% 	(17%) 	(3%) 	3% 	(1%) 	24% 	(12%) (12%) 	18%
Adjusted Compensation and Benefits Expense 	832 1,024 	939 1,014 1,132 	524 	628 	558 	545 	603 	146 	184 	160 	143 	168
Adjusted Compensation Ratio (n) 	59% 	58% 	57% 	75% 	65% 	47% 	47% 	51% 	51% 	55% 	6% 	6% 	6% 	6% 	6%
Adjusted Non-Compensation Expenses 	144 	160 	184 	194 	202 	175 	195 	205 	219 	230 	113 	117 	129 	159 	143
Adjusted Non-Compensation Ratio (p) 	10% 	9% 	11% 	14% 	12% 	16% 	15% 	19% 	21% 	21% 	4% 	4% 	5% 	7% 	5%
Adjusted Operating Income 	$427 	$594 	$529 	$149 	$397 	$413 	$505 	$336 	$303 	$267 	$590 	$831 	$594 	$166 	$411
Adjusted Operating Margin (q) 	30% 	33% 	32% 	11% 	23% 	37% 	38% 	31% 	28% 	24% 	23% 	26% 	21% 	7% 	14%
Asset Management 1 	Corporate 2	
Financial Advisory 1

-- 41 of 43 --

2020 	2021 	2022 	2023 	2024 	2020 	2021 	2022 	2023 	2024 	2020 	2021 	2022 	2023 	2024 	2020 	2021 	2022 	2023 	2024
Net Revenue - U.S. GAAP Basis 	$1,421 $1,765 $1,666 $1,385 $1,756 	$1,167 $1,425 $1,205 $1,151 $1,187 	($22) 	$4 	($98) 	($21) 	$109 	$2,566 $3,193 $2,774 $2,515 $3,052
Adjustments 1
Revenue related to noncontrolling interests and similar arrangements (c) 	- 	- 	- 	- 	- 	(8) 	(22) 	(44) 	(16) 	(22) 	(3) 	(10) 	(5) 	(14) 	(7) 	(11) 	(32) 	(49) 	(30) 	(30)
(Gains) losses related to Lazard Fund Interests ("LFI") and other similar arrangements (d) 	- 	- 	- 	- 	- 	- 	- 	- 	- 	- 	(41) 	(35) 	44 	(41) 	(16) 	(41) 	(35) 	44 	(41) 	(16)
Distribution fees, reimbursable deal costs, provision for credit losses and other (e) 	(17) 	(10) 	(14) 	(31) 	(26) 	(48) 	(75) 	(62) 	(68) 	(65) 	- 	- 	(0) 	(8) 	- 	(65) 	(85) 	(76) 	(106) 	(91)
Interest expense (f) 	- 	- 	0 	0 	0 	- 	- 	0 	0 	0 	74 	74 	76 	77 	88 	74 	74 	77 	77 	88
Gain on sale of property (h) 	- 	- 	- 	- 	- 	- 	- 	- 	- 	- 	- 	- 	- 	- 	(114) 	- 	- 	- 	- 	(114)
Other (r) 	- 	24 	- 	2 	1 	- 	- 	- 	- 	- 	- 	- 	- 	22 	- 	- 	24 	- 	24 	1
Adjusted Net Revenue 	$1,403 $1,778 $1,652 $1,357 $1,731 	$1,111 $1,329 $1,099 $1,068 $1,100 	$9 	$33 	$18 	$15 	$59 	$2,524 $3,139 $2,769 $2,440 $2,890
Operating Income (Loss) - U.S. GAAP Basis 	$290 	$408 	$361 	($105) 	$193 	$306 	$392 	$241 	$140 	$149 	($94) 	($76) 	($86) 	($115) 	$45 	$502 	$724 	$517 	($80) 	$386
Adjustments:
Sum of Adjustments - Net Revenue - U.S. GAAP vs. Adjusted GAAP (from above) 	(17) 	13 	(14) 	(29) 	(25) 	(56) 	(96) 	(106) 	(84) 	(87) 	31 	29 	115 	37 	(50) 	(42) 	(54) 	(5) 	(76) 	(162)
Operating expenses related to noncontrolling interests and similar arrangements (c) 	- 	- 	- 	- 	- 	10 	11 	13 	11 	22 	0 	6 	1 	1 	1 	10 	17 	14 	12 	23
Charges (credits) pertaining to LFI and other similar arrangements (j) 	- 	- 	- 	- 	- 	- 	- 	- 	- 	- 	41 	35 	(44) 	41 	16 	41 	35 	(44) 	41 	16
Distribution fees, reimbursable deal costs, provision for credit losses and other (e) 	17 	10 	14 	31 	26 	48 	75 	62 	68 	65 	- 	- 	- 	8 	- 	65 	85 	76 	106 	91
Amortization and other acquisition-related costs 	0 	- 	- 	- 	- 	2 	- 	0 	0 	0 	- 	- 	- 	- 	- 	2 	- 	0 	0 	0
Provision (benefit) pursuant to the tax receivable agreement ("TRA") (b) 	- 	- 	- 	- 	- 	- 	- 	- 	- 	- 	0 	2 	(1) 	(44) 	(8) 	0 	2 	(1) 	(44) 	(8)
Corporate support group allocations to business segments (s) 	137 	146 	154 	151 	170 	105 	123 	114 	109 	106 	(241) 	(269) 	(268) 	(260) 	(277) 	- 	- 	- 	- 	-
Expenses associated with cost-saving initiatives 	- 	- 	- 	101 	33 	- 	- 	- 	58 	12 	- 	- 	- 	37 	4 	- 	- 	- 	195 	48
Other (r) 	- 	16 	13 	- 	- 	- 	- 	12 	2 	- 	13 	5 	12 	9 	17 	13 	21 	37 	11 	17
Total Adjustments 	$137 	$186 	$167 	$253 	$204 	$107 	$113 	$94 	$163 	$118 	($156) 	($192) 	($185) 	($171) 	($298) 	$88 	$107 	$77 	$245 	$24
Adjusted Operating Income (Loss) 	$427 	$594 	$529 	$149 	$397 	$413 	$505 	$336 	$303 	$267 	($250) 	($268) 	($270) 	($287) 	($253) 	$590 	$831 	$594 	$166 	$411
Adjusted Operating Margin (q) 	30% 	33% 	32% 	11% 	23% 	37% 	38% 	31% 	28% 	24% 	nm 	nm 	nm 	nm 	nm 	23% 	26% 	21% 	7% 	14%
Financial Advisory 	Asset Management 	Corporate 	Total Firm

-- 42 of 43 --



-- 43 of 43 --